AstraZeneca Inks China AI Research Deal For Chronic Diseases

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases.

Related Posts

Real Or Photoshopped? Joe Biden's Family Photo Raises E...

rvrising Apr 23, 2025  0

Message From Elon Musk's Father Backing Tesla Manufactu...

rvrising Jun 3, 2025  0

Over 170 Arrested Over Attacks On KFC Outlets In Pakistan

rvrising Apr 18, 2025  0

Comments

Name

Email

Comment

Post Comment